JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 5 No. 1 1-8
© 1964 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinn, J. L.
Right arrow Articles by Watts, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, J. L., III
Right arrow Articles by Watts, F. C.

An Approach to the Scanning of Pulmonary Infarcts1,2,

James L. Quinn, III, M.D. 3, Joseph E. Whitley, M.D. 4, Allen S. Hudspeth, M.D. 5 and Finley C. Watts, B.S.

Winston-Salem, North Carolina

ABSTRACT

1. A simple embolus technique for producing pulmonary infarcts in mongrel dogs is described. It was successful in 43 of 44 instances where the embolus could be located within the pulmonary artery system.
2. Three radiopharmaceuticals viz. Cr51 tagged red blood cells, I131 human serum albumin and Hg203 chlormerodrin were evaluated as to their possible efficiency in detecting such infarcts. Chlormerodrin was the only one found to be promising.
3. Successful scans of the pulmonary infarct outside of the chest were obtained. No attempt was made to scan the lungs inflated or within the chest.
4. Hg203 chlormerodrin is not likely to be a satisfactory compound for detecting pulmonary infarcts in clinical practice, particularly in regard to scanning the lower lobes of the lungs, due to interference from liver, spleen and renal activity.
5. The described experimental technique is probably satisfactory for initial screening of other radiopharmaceuticals for possible use in the detection of pulmonary infarction.

FOOTNOTES

1 Departments of Radiology and Surgery, Bowman Gray School of Medicine.

2 This project was supported by a grant from the Fluid Research Funds of the Bowman Gray School of Medicine.

3 Fellow, American Cancer Society.

4 Senior Investigator in Clinical Research, N.C. Heart Association.

5 Research Fellow, National Institutes of Health (Heart Institute).







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1964 by the Society of Nuclear Medicine.